Lewis B Silverman

Board Member at ENZYME BY DESIGN

Director of Clinical Research and Clinical Care at the Dana-Farber Cancer Institute (DFCI), Associate Chief of Pediatric Oncology at Boston Children’s Hospital, and Professor of Pediatrics at the Harvard Medical School.

Dr. Silverman’s major research focus is in childhood ALL, and is Chair of the DFCI ALL Consortium, which runs multi-center clinical trials in children and adolescents with newly diagnosed ALL. He is a renowned KOL in ALL and has pioneered new treatments and approaches aimed at improving survival rates.